To screen or not to screen: Ongoing debate in the early detection of prostate cancer - Abstract

Department of Nursing, University of Pennsylvania, Philadelphia, USA.

Debate about the use of prostate-specific antigen (PSA) tests to screen prostate cancer in men is ongoing. Prostate cancer is the most common cancer after skin cancer in men and the second most deadly after lung cancer. An elevated PSA level can lead to this cancer's diagnosis and treatment even before the onset of symptoms. However, other causes also can create a high PSA level, which may lead to men being unnecessarily treated for prostate cancer. This article will shed some light on the issue and discuss prostate cancer screening.

Written by:
Marroquin JM.   Are you the author?

Reference: Clin J Oncol Nurs. 2011 Feb 1;15(1):97-8.
doi: 10.1188/11.CJON.97-98

PubMed Abstract
PMID: 21278045

UroToday.com Prostate Cancer Section

email news signup